Hepatic adenoma
Hello Doctor, my mother is 60 years old.
She was diagnosed with stage 1A gastric cancer in August 2018 and underwent surgical treatment.
Since then, she has been undergoing annual check-ups.
In July 2020, an abdominal CT scan revealed a small nodule in the liver.
An MRI performed in September reported, "An approximately 8.4 x 12.6 mm enhancing nodule is seen adjacent to the capsule in the posterior segment of the right lobe of the liver during early arterial phase enhancement.
Delayed scans and plain images did not clearly demonstrate it, showing isodensity.
This is considered possibly related to arterial supply from the hepatic capsule collateral branches, but follow-up imaging is necessary." (Please excuse any differences in terminology as this was done at a hospital abroad.) My mother does not have hepatitis B or C, does not consume alcohol, and has normal liver function.
How should this nodule be interpreted, Doctor? As a family member, I am quite worried.
Thank you for taking the time to read and respond.
Wishing you well.
Xiao An, 30~39 year old female. Ask Date: 2021/06/29
Dr. Chen Shidian reply Gastroenterology and Hepatology
Please follow up or refer the imaging to a radiologist to determine if additional examinations are needed.
Reply Date: 2021/06/29
More Info
Understanding liver nodules can be a source of concern for families, especially when there is a history of cancer, as in your mother's case. Based on the information provided, your mother has a history of stage 1A gastric cancer, which was treated surgically, and she has been undergoing regular check-ups since then. The recent imaging studies have revealed a small liver nodule, which has raised questions about its nature and potential implications.
Interpretation of the Liver Nodule
The MRI report describes a nodule measuring approximately 8.4 x 12.6 mm in the right lobe of the liver, which shows early enhancement during the arterial phase of imaging. This enhancement pattern can suggest several possibilities, including:
1. Hemangioma: This is a benign vascular tumor of the liver that often presents as a hypervascular lesion on imaging. Hemangiomas are typically asymptomatic and do not require treatment unless they are large or symptomatic.
2. Focal Nodular Hyperplasia (FNH): Another benign lesion that can appear similar to a hemangioma. FNH is characterized by a central scar and is usually asymptomatic.
3. Hepatic Adenoma: This is a benign tumor that can occur in the liver, often associated with hormonal influences, particularly in women. These can sometimes cause symptoms or complications, especially if they are large.
4. Malignant Lesions: While the enhancement pattern could suggest a benign process, it is essential to consider the possibility of malignancy, especially given your mother's cancer history. However, the absence of risk factors such as hepatitis B or C, alcohol use, and normal liver function tests are reassuring.
Follow-Up Recommendations
Given the findings, it is crucial to follow the recommendation for periodic re-evaluation of the nodule. The suggestion for follow-up imaging is standard practice to monitor any changes in size or characteristics of the nodule. If the nodule remains stable over time, it is more likely to be benign. However, if there are changes in size or enhancement patterns, further evaluation may be warranted, which could include:
- Repeat Imaging: Scheduled follow-up CT or MRI scans to monitor the nodule over time.
- Biopsy: If there are concerning features or significant changes, a biopsy may be considered to obtain a definitive diagnosis.
Family Concerns and Support
It is entirely normal for family members to feel anxious about such findings, especially with a history of cancer. Open communication with your mother's healthcare team is essential. They can provide detailed explanations of the imaging findings, the rationale for follow-up, and what to expect moving forward.
Additionally, consider discussing any symptoms your mother may experience, such as unexplained weight loss, abdominal pain, or changes in appetite, as these could be relevant to her overall health and the management of the liver nodule.
Conclusion
In summary, the liver nodule described in your mother's imaging studies requires careful monitoring. The characteristics of the nodule, along with her medical history, suggest that it may be benign, but follow-up imaging is essential to ensure that it remains stable. Encourage your mother to maintain her regular check-ups and to communicate openly with her healthcare providers about any concerns. This proactive approach will help alleviate anxiety and ensure that any necessary interventions are made promptly.
Similar Q&A
Understanding Liver Nodules: Causes, Risks, and Management Options
Hello Dr. Chen, Recently, my mother (49 years old) underwent a comprehensive health check-up at Chang Gung Memorial Hospital. The report indicated that she has a 2.5 cm liver nodule, liver cysts, and fatty liver, but she does not have hepatitis B. Could you please explain whethe...
Dr. Chen Zhiping reply Gastroenterology and Hepatology
Hello, the term "nodule" refers to a small mass of tissue, which generally raises suspicion for a tumor; however, it can be either benign or malignant. I'm not sure how the physician explained this to you at the time. As for liver cysts, they are benign fluid-fille...[Read More] Understanding Liver Nodules: Causes, Risks, and Management Options
Understanding Liver Nodules: What You Need to Know After Your Ultrasound
Hello, I had a health check-up in August this year, and the ultrasound revealed three hypoechoic nodules in my liver (1.44 cm in segment 2, 0.97 cm in segment 4, and 1.64 cm in segment 7), along with mild fatty liver. My AFP levels are normal, and I have antibodies for hepatitis ...
Dr. Lin Minghui reply Gastroenterology and Hepatology
Hello, a 26-year-old male underwent a health check and was found to have fatty liver and three hypoechoic liver nodules measuring less than 2 cm, with a family history of liver cancer. The differential diagnosis for liver nodules is extensive, including benign hepatic steatosis, ...[Read More] Understanding Liver Nodules: What You Need to Know After Your Ultrasound
Understanding Liver Nodules: CT Scan Insights and Further Evaluation
1. Typically, a CT scan can provide an initial assessment of whether a liver nodule is benign or malignant. However, certain characteristics of the nodule may require further evaluation to make a definitive diagnosis. 2. The recommendation for further evaluation with MRI may ari...
Dr. Hong Yuanbin reply Internal Medicine
Hello, 1. A CT scan can indeed provide an initial assessment to suggest whether a lesion may be benign or malignant; however, confirmation requires further testing, such as a biopsy. 2. A CT scan serves as an initial evaluation, and further procedures like a biopsy or MRI are nec...[Read More] Understanding Liver Nodules: CT Scan Insights and Further Evaluation
Understanding Chronic Hepatitis B: Key Questions and Concerns
Hello Doctor: First, I would like to share my family's medical history: My mother was once your patient and passed away at 55 due to severe jaundice, ascites, and cirrhosis caused by hepatitis B. My grandmother also died from liver disease. My uncle passed away at 48 due to ...
Dr. Xu Jinchuan reply Gastroenterology and Hepatology
Hello! 1. To qualify for health insurance coverage, you need to have an e-antigen report. I'm not sure if you have been tested for this, as well as for Hepatitis C and Hepatitis D. Since your GPT level is above 200, if the e-antigen is positive and Hepatitis C and D infectio...[Read More] Understanding Chronic Hepatitis B: Key Questions and Concerns
Related FAQ
(Gastroenterology and Hepatology)
Liver Tumor(Gastroenterology and Hepatology)
Hepatic Hemangioma(Gastroenterology and Hepatology)
Cancer(Gastroenterology and Hepatology)
Liver Fibrosis(Gastroenterology and Hepatology)
Jaundice(Gastroenterology and Hepatology)
Navel(Gastroenterology and Hepatology)
Fatty Liver(Gastroenterology and Hepatology)
Hepatitis B(Gastroenterology and Hepatology)
Polyps(Gastroenterology and Hepatology)